Elsevier, Epilepsy Research, (127), p. 93-100
DOI: 10.1016/j.eplepsyres.2016.08.021
Full text: Unavailable
To evaluate the efficacy and tolerability of Perampanel (PER) in children and adolescents with refractory epilepsies in daily clinical practice conditions.